close

IGI Laboratories, Inc. engages in the development, manufacture, filling, and packaging of topical, semi solid, and liquid products for pharmaceutical, cosmeceutical, and cosmetic companies. The company focuses on the commercialization of its licensed Novasome encapsulation technology for skin care/treatment products. It licenses the Novasome encapsulation technology from Novavax, Inc. for applications in animal pharmaceuticals, biologicals, and other animal health products; foods, food applications, nutrients, and flavorings; cosmetics, consumer products, and dermatological over-the-counter and prescription products; fragrances; and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals, and other specialty chemicals, as well as the processes for making the same. The company was formerly known as IGI, Inc. and changed its name to IGI Laboratories, Inc. in May 2008. IGI Laboratories, Inc. was founded in 1977 and is headquartered in Buena, New Jersey.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	1.15
Volume	1900
Volume Avg	9037
52 Week High	1.64
52 Week Low	0.85
PE	N/A
PE (group average)	39
EPS Year	-0.08
EPS change Q/Q	-200%
EPS change Q/Q Yr ago	-57.14%
EPS change Q/Q next Q est	100%
EPS change Y/Y	-127.78%
REV change Q/Q	-5.88%
REV change Q/Q Yr ago	77.78%
EPS next Q est	0.00
EPS next Y est	0.00
Divident Annual	0.00
Dividend Yield	0%